July 2022
Pharmaceutical industry in the Middle East
As per our Allianz latest report, dated on 15 June 2022, on potential trade recession before the reopening of China, we can see now that improving supply chain from China would bring the largest production to the agrifood and pharma sectors and IT services sectors in Europe and in the US.
Using the database to map our global production chains that involve Chinese suppliers, we estimate an increase by over +5% for each sector in the second half of the year compared to last year’s levels.
This boost in output should be stocked or solved, the latter helping to reinforce the inventory buffer against potential future shocks (e.g. if the zero-Covid policy is maintained throughout 2022 in China).
Coming to the Middle East region, the Gulf Arab countries’ medical industry is picking up fast.m SARS-CoV-2 has propelled the industry in all countries in the region. The industrial landscape, however, remains fragmented with the UAE and Saudi Arabia taking a lead.
Please read the full report detailing how the Gulf Arab states lift their homegrown pharmaceutical industry and healthcare sectors to the next level.
Fill out the form below to receive the full version of the report
"Pharmaceutical industry in Middle East"
"Pharmaceutical industry in Middle East"